n(g),n(g')-dimethyl-l-arginine has been researched along with Arterial Obstructive Diseases in 9 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated in this double-blind, controlled study whether prolonged intermittent infusion therapy with L-arginine improves the clinical symptoms of patients with intermittent claudication, as compared with the endothelium-independent vasodilator prostaglandin E1, and control patients." | 9.08 | Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. ( Alexander, K; Bode-Böger, SM; Böger, RH; Creutzig, A; Frölich, JC; Thiele, W, 1998) |
| "Hyperhomocysteinemia is associated with an enhanced risk for cardiovascular disease." | 7.72 | Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA. ( Arakawa, N; Bode-Böger, SM; Böger, RH; Hornig, B; Münzel, T; Sydow, K; Tsikas, D, 2004) |
| "We investigated in this double-blind, controlled study whether prolonged intermittent infusion therapy with L-arginine improves the clinical symptoms of patients with intermittent claudication, as compared with the endothelium-independent vasodilator prostaglandin E1, and control patients." | 5.08 | Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. ( Alexander, K; Bode-Böger, SM; Böger, RH; Creutzig, A; Frölich, JC; Thiele, W, 1998) |
| "Hyperhomocysteinemia is associated with an enhanced risk for cardiovascular disease." | 3.72 | Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA. ( Arakawa, N; Bode-Böger, SM; Böger, RH; Hornig, B; Münzel, T; Sydow, K; Tsikas, D, 2004) |
| " Mechanisms responsible for endothelial dysfunction in hyperhomocyst(e)inemia may involve impaired bioavailability of NO, possibly secondary to accumulation of the endogenous NO synthase inhibitor asymmetric dimethylarginine (ADMA) and increased oxidative stress." | 2.71 | ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins. ( Arakawa, N; Bode-Böger, SM; Böger, RH; Frölich, JC; Hornig, B; Schwedhelm, E; Sydow, K; Tsikas, D, 2003) |
| "Patients with type 2 diabetes (T2DM) have higher incidence of macrovascular disease than the general population." | 1.33 | Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes. ( Hofer, M; Krugluger, W; Krzyzanowska, K; Mittermayer, F; Schernthaner, G; Schnack, C; Wolzt, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oz, O | 1 |
| Gökçil, Z | 1 |
| Bek, S | 1 |
| Cakir, E | 1 |
| Odabaşi, Z | 1 |
| Sydow, K | 2 |
| Schwedhelm, E | 1 |
| Arakawa, N | 2 |
| Bode-Böger, SM | 5 |
| Tsikas, D | 3 |
| Hornig, B | 2 |
| Frölich, JC | 3 |
| Böger, RH | 5 |
| Münzel, T | 1 |
| Krzyzanowska, K | 1 |
| Mittermayer, F | 1 |
| Krugluger, W | 1 |
| Schnack, C | 1 |
| Hofer, M | 1 |
| Wolzt, M | 1 |
| Schernthaner, G | 1 |
| Blardi, P | 1 |
| de Lalla, A | 1 |
| Pieragalli, D | 1 |
| De Franco, V | 1 |
| Meini, S | 1 |
| Ceccatelli, L | 1 |
| Auteri, A | 1 |
| Lücke, T | 1 |
| Kanzelmeyer, NK | 1 |
| Boerkoel, CF | 1 |
| Clewing, JM | 1 |
| Vaske, B | 1 |
| Ehrich, JH | 1 |
| Das, AM | 1 |
| Thiele, W | 2 |
| Junker, W | 1 |
| Alexander, K | 2 |
| Creutzig, A | 1 |
1 review available for n(g),n(g')-dimethyl-l-arginine and Arterial Obstructive Diseases
| Article | Year |
|---|---|
[Endothelial dysfunction in peripheral arterial occlusive disease: from basic research to clinical use].
Topics: Arginine; Arterial Occlusive Diseases; Arteriosclerosis; Endothelium, Vascular; Humans; Nitric Oxide | 1997 |
3 trials available for n(g),n(g')-dimethyl-l-arginine and Arterial Obstructive Diseases
| Article | Year |
|---|---|
ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.
Topics: Aged; Analysis of Variance; Arginine; Arterial Occlusive Diseases; Double-Blind Method; Female; Foli | 2003 |
Effect of iloprost on plasma asymmetric dimethylarginine and plasma and platelet serotonin in patients with peripheral arterial occlusive disease.
Topics: Aged; Aged, 80 and over; Arginine; Arterial Occlusive Diseases; Blood Platelets; Blood Pressure; Dia | 2006 |
Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
Topics: Aged; Aged, 80 and over; Alprostadil; Arginine; Arterial Occlusive Diseases; Blood Flow Velocity; Ch | 1998 |
5 other studies available for n(g),n(g')-dimethyl-l-arginine and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Is asymmetric dimethylarginine responsible for the vascular events in patients under antiepileptic drug treatment?
Topics: Adult; Anticonvulsants; Arginine; Arterial Occlusive Diseases; Carbamazepine; Drug Monitoring; Epile | 2009 |
Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Arterial Occlusive Diseases; Chronic Disease; Endothelium, | 2004 |
Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
Topics: Aged; Arginine; Arterial Occlusive Diseases; Biomarkers; Chromatography, High Pressure Liquid; Cross | 2006 |
Vaso-occlusion in Schimke-immuno-osseous dysplasia: is the NO pathway involved?
Topics: Adolescent; Adult; Arginine; Arterial Occlusive Diseases; Atherosclerosis; Child; Child, Preschool; | 2006 |
Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease.
Topics: Adult; Aged; Aged, 80 and over; Aging; Arginine; Arterial Occlusive Diseases; Cyclic GMP; Disease Pr | 1997 |